Biosurfactants Market worth 5.52 Billion USD by 2022

By -

The global biosurfactants market was valued at USD 3.99 Billion in 2016 and is projected to reach USD 5.52 Billion by 2022, at a CAGR of 5.6% during the forecast period.

(EMAILWIRE.COM, January 24, 2018 ) The report "Biosurfactants Market by Type (Glycolipids (Sophorolipids, Rhamnolipids), Lipopeptides, Phospholipids, Polymeric Biosurfactants), Application (Detergents, Personal Care, Agricultural Chemicals, Food Processing), and Region - Global Forecast to 2022", The global biosurfactants market is estimated at USD 4.20 Billion in 2017 and projected to reach USD 5.52 Billion by 2022, at a CAGR of 5.6% from 2017 to 2022

Browse 86 market data Tables and 25 Figures spread through 114 Pages and in-depth TOC on "Biosurfactants Market by Type (Glycolipids (Sophorolipids, Rhamnolipids), Lipopeptides, Phospholipids, Polymeric Biosurfactants), Application (Detergents, Personal Care, Agricultural Chemicals, Food Processing), and Region - Global Forecast to 2022"

https://www.marketsandmarkets.com/Market-Reports/biosurfactant-market-163644922.html

Early buyers will receive 10% customization on reports.

The growth of the global biosurfactants market is mainly driven by the increasing demand for renewable and biodegradable products. Green products or biologically derived biosurfactants exhibit enhanced functionality as compared to chemically derived surfactants. By using natural raw materials, the products so developed are environment friendly.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=163644922

The rhamnolipid segment is projected to grow at the highest CAGR between 2017 and 2022

Based on type, the global biosurfactants market has been segmented into glycolipids and lipopeptides. Rhamnolipids, falling under the glycolipids segment is projected to grow at the highest CAGR during the forecast period. This expected high growth rate is due to the increasing need for highly-efficient and cost-effective biosurfactants having superior properties as compared to chemical surfactants.

The agricultural chemicals application segment is projected to grow at the highest CAGR during the forecast period

Based on application, the agricultural chemicals segment is projected to grow at the highest CAGR between 2017 and 2022. Increasing demand for green surfactants to improve soil conditions, indirect plant growth promotion, and plant microbe interaction is fueling the growth of the biosurfactants market globally.

Asia Pacific to be the fastest-growing market for biosurfactants during the forecast period

The biosurfactants market in the Asia Pacific region is projected to grow at the highest CAGR between 2017 and 2022. This growth is mainly attributed to the rise of personal care, agriculture, and home care industries; significant R&D investments; and drive to use green products in the Asia Pacific countries, such as India, South Korea, and China. Europe accounted for the largest share of the global biosurfactants market in 2016, and is expected to continue to lead during the forecast period. This is due to the early product commercialization, intensive R&D, and rapid adoption of biosurfactants by general consumers in this region.

Speak To Analyst: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=163644922

Ecover (Belgium), Logos Technologies (US), Evonik (Germany), Soliance (France), AGAE Technologies (US), and Jeneil Biotech (US) are some of the leading players in the global biosurfactants market.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Media Contact

Related Tags

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more